Cypherpunk Technologies, Inc. (CYPH)
3.67
+0.27
(+7.94%)
USD |
NASDAQ |
Sep 22, 12:07
Cypherpunk Technologies Price to Book Value : 2.839 for Sept. 22, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 21, 2026 | 2.630 |
| September 18, 2026 | 2.785 |
| September 17, 2026 | 2.375 |
| September 16, 2026 | 1.887 |
| September 15, 2026 | 1.717 |
| September 14, 2026 | 1.996 |
| September 11, 2026 | 1.752 |
| September 10, 2026 | 1.702 |
| September 09, 2026 | 1.895 |
| September 08, 2026 | 2.034 |
| September 04, 2026 | 1.872 |
| September 03, 2026 | 1.756 |
| September 02, 2026 | 1.300 |
| September 01, 2026 | 1.323 |
| August 31, 2026 | 1.412 |
| August 28, 2026 | 1.323 |
| August 27, 2026 | 1.462 |
| August 26, 2026 | 1.261 |
| August 25, 2026 | 1.269 |
| August 24, 2026 | 1.300 |
| August 21, 2026 | 1.098 |
| August 20, 2026 | 0.9205 |
| August 19, 2026 | 0.8277 |
| August 18, 2026 | 0.623 |
| August 17, 2026 | 0.5456 |
| Date | Value |
|---|---|
| August 14, 2026 | 0.4981 |
| August 13, 2026 | 0.5012 |
| August 12, 2026 | 0.5089 |
| August 11, 2026 | 0.526 |
| August 10, 2026 | 0.5258 |
| August 07, 2026 | 0.5326 |
| August 06, 2026 | 0.5212 |
| August 05, 2026 | 0.567 |
| August 04, 2026 | 0.5337 |
| August 03, 2026 | 0.4926 |
| July 31, 2026 | 0.4568 |
| July 30, 2026 | 0.4839 |
| July 29, 2026 | 0.4648 |
| July 28, 2026 | 0.475 |
| July 27, 2026 | 0.4848 |
| July 24, 2026 | 0.4807 |
| July 23, 2026 | 0.5113 |
| July 22, 2026 | 0.52 |
| July 21, 2026 | 0.5716 |
| July 20, 2026 | 0.5545 |
| July 17, 2026 | 0.5477 |
| July 16, 2026 | 0.5511 |
| July 15, 2026 | 0.5821 |
| July 14, 2026 | 0.5661 |
| July 13, 2026 | 0.5405 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.510 |
| Alnylam Pharmaceuticals, Inc. | 25.07 |
| Anika Therapeutics, Inc. | 2.035 |
| Savara, Inc. | 7.764 |
| Vericel Corp. | 5.525 |
Price to Book Value Related Metrics
| PE Ratio | 6.489 |
| Price | 3.67 |
| Earnings Yield | 15.41% |
| Market Cap | 395.50M |